Encellin’s platform harnesses material chemistry innovation to advance dynamic and responsive next-generation cell therapies as living medicines. Their goal is to provide functional cures for people with unmet clinical needs, starting with metabolic diseases. Early in the company’s development, Encellin’s founders felt fortunate to be
introduced to First Republic. The Bank helped streamline their day-to-day operations, guiding them to the right products and services for each stage of growth. With a committed banking partner by their side, Encellin is better able to focus on their mission to help millions of patients around the world.